Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in adults with type 2 diabetes on peritoneal dialysis
ACTRN12612000864820Phase 2Not yet recruiting
- Sponsor
- Tilenka Thynne
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Tilenka Thynne. Primary endpoints: Pharmacokinetics of metformin in the setting of peritoneal dialysis and Safety of metformin in peritoneal dialysis. Planned start Sep 2012; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12612000864820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000864820.